Asensus Surgical, Inc. (ASXC) |
|
0.83 -0.012 (-1.39%)
|
01-27 16:00 |
|
Open: |
0.84 |
Pre. Close: |
0.8417 |
|
High:
|
0.874 |
Low:
|
0.7801 |
|
Volume:
|
2,247,442 |
Market Cap:
|
197(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:42:38 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 1.02  One year: 1.19 |
| Support: |
Support1: 0.5 Support2: 0.28 |
| Resistance: |
Resistance1: 0.87 Resistance2: 1.02 |
| Pivot: |
0.62 |
| Moving Average: |
MA(5): 0.74 MA(20): 0.55
MA(100): 0.45 MA(250): 0.5 |
| MACD: |
MACD(12,26): 0.1 Signal(9): 0 |
| Stochastic oscillator: |
%K(14,3): 92.1 %D(3): 90.7 |
| RSI: |
RSI(14): 79.8  |
| 52-week: |
High: 0.92 Low: 0.28 |
| Average Vol(K): |
3-Month: 1,129 (K) 10-Days: 2,500 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ASXC ] has closed below upper band by 8.9%. Bollinger Bands are 238.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 14 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.88 - 0.88 |
0.88 - 0.88 |
|
Low:
|
0.77 - 0.78 |
0.78 - 0.78 |
|
Close:
|
0.82 - 0.83 |
0.83 - 0.84 |
|
Company Description |
|
Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina. |
Headline News |
Fri, 27 Jan 2023
Is Asensus Surgical Inc (ASXC) a Stock to Watch After Gaining 23.88% This Week? - InvestorsObserver
Fri, 27 Jan 2023
Market cap of Asensus Surgical Inc. [ASXC] reaches 200.64M – now ... - DBTNews
Fri, 27 Jan 2023
Asensus Surgical Inc. (AMEX:ASXC) Is Up 169.69% Over The Past ... - Marketing Sentinel
Thu, 26 Jan 2023
7 Top Penny Stocks Under $1 To Watch Before Next Week - Penny Stocks
Mon, 23 Jan 2023
Asensus Surgical wins CE mark for surgical robot's machine vision - Mass Device
Thu, 19 Jan 2023
Should You Add Asensus Surgical Inc (ASXC) Stock to Your ... - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Underperform |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Underperform |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: AMEX |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
0 (M) |
| Shares Float |
237 (M) |
|
% Held by Insiders
|
2.3309e+008 (%) |
|
% Held by Institutions
|
1 (%) |
|
Shares Short
|
8,670 (K) |
|
Shares Short P.Month
|
0 (K) |
Stock Financials |
|
EPS
|
-6.331e+007 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
0 |
|
Profit Margin (%)
|
0 |
|
Operating Margin (%)
|
-1 |
|
Return on Assets (ttm)
|
78.3 |
|
Return on Equity (ttm)
|
-29.2 |
|
Qtrly Rev. Growth
|
7.1e+006 |
|
Gross Profit (p.s.)
|
-0.01 |
|
Sales Per Share
|
0.02 |
|
EBITDA (p.s.)
|
-0.2 |
|
Qtrly Earnings Growth
|
-0.3 |
|
Operating Cash Flow
|
0 (M) |
|
Levered Free Cash Flow
|
-58 (M) |
Stock Valuations |
|
PE Ratio
|
-0.01 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
0 |
|
Price to Sales
|
28.35 |
|
Price to Cash Flow
|
0 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
8.82e+006 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2019-12-11 |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
